F&P Healthcare has forecast revenue of $1.075b and net profit of $200m for the half.
About 20-odd companies are due to report results over the next few weeks.
Shares in a2 Milk have rallied by about 77% so far this year.
ASB says at 18% above its 200-day average, the Nasdaq 100 is near bubble levels.
Founder Alan Bougen is rallying investors to oppose the Florenz bid.
In other news, Miles Hurrell starts cashing in on his incentive plan.
The NZ sharemarket has recovered 12% from its lows in April this year.
Ebos shares have slumped 29% since hitting a peak of $41.25 on August 21.
The company booked a credit impairment charge of $39.8m in the 15 months to March 31.
What the latest company reporting season tells us about the state of the economy.
ANZ had the biggest market share of Kiwisaver in the June quarter, followed by ASB.
Will this month's company reporting season reveal a turnaround for the sharemarket?
Sky expects a $20m ebitda improvement from cost synergies over three years.
Australian fund manager ROC Partners is said to 'like the look' of the apple grower.
Hydro storage in New Zealand is now above the long-run average, thanks to heavy rain.
KiwiSaver funds have about $35 billion in US equities.
The New Zealand sharemarket has fallen 5% in the first half, while others have gained.
BGH's tilt at Tourism Holdings has sparked more merger and acquisition speculation.
Fletcher Building, Spark and Ryman are potentially all on the radar.
Plus: Auckland Airport and Spark are back in favour with analysts at Morningstar.
Rising world bond yields are unsettling sharemarket investors.
Sybos sold 27m Ebos shares - first sale since 2020.
An overhang on the stock is weighing on the retirement village operator's share price.
Analyst says risks in Fonterra-Bega legal tangle have been overstated.
Fisher and Paykel Healthcare will be the main event when it reports on May 28.
Mercury, Meridian and Manawa are likely to be hit hardest by the earlier drought.
Surf's up for the telco as its capital-raising effort comes to the sharp end.
PLUS: Blackbird gears up for $1 billion raise.
New Zealand's sharemarket is in correction mode, but is faring better than others.
Fonterra's Mainland sale process continues despite a turbulent sharemarket.
